Well I'm no expert in MCTT (Medical Clinical Trial Timelines) but Im guessing you could minus 3 months from Prep time (trial design, Pre 3 meetings with FDA etc), and at least another 3 months for recruitment and then a full 1 year min for the trial and then 6 months to review results, whats that, a total of say 2 years saving. Thats the whole idea, its such a critically required drug, its safe and there is NOTHING else that can be currently used, its filling an unmet need. SO instead of it being 1.5 years (Phase 2) plus 2 years min (Phase 3), we might get away with just 2 years all up before commercialisation. This is also postulated by 51Capital who suggested something like a 2021 release for PPS to combat MPS.
Long time frames sure, but hey, 2 years is better than 4 plus.
Do your own research, these are just my opinions.
PAR Price at posting:
$1.56 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)